University Hospital Schleswig-holstein
Clinical trials sponsored by University Hospital Schleswig-holstein, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- App aims to catch a hidden radiotherapy side effect Results expected Oct 2026 (estimated)
- Phone app aims to keep lung cancer patients moving during treatment Results expected Feb 2027 (estimated)
- Lifestyle overhaul may slow Parkinson's onset Results expected Sep 2027 (estimated)
-
New trial puts mirikizumab Head-to-Head with standard Crohn's therapy
Disease control Not yet recruitingThis study compares early treatment with mirikizumab (a biologic drug) to standard therapy with azathioprine plus steroids in 320 adults newly diagnosed with moderate-to-severe Crohn's disease. Participants are randomly assigned to one of two groups for 52 weeks. The goal is to s…
Phase 4 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
App aims to catch a hidden radiotherapy side effect
Diagnosis Not yet recruitingRadiation pneumonitis is a lung inflammation that can appear weeks after radiotherapy for lung cancer, and patients may not link their symptoms to the earlier treatment. Researchers developed a smartphone app called PneumoCheck for patients to use at home, hoping it helps detect …
Sponsor: University Hospital Schleswig-Holstein • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Lifestyle overhaul may slow Parkinson's onset
Prevention Not yet recruitingThis study tests whether a 6-month program combining exercise, Mediterranean diet, sleep counseling, and cognitive training can help people with early Parkinson's or a sleep disorder (RBD) stick to healthy habits. Researchers will track how well 99 participants follow the program…
Sponsor: University Hospital Schleswig-Holstein • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Can a vitamin B3 tablet help restore energy in long COVID?
Symptom relief Not yet recruitingThis study tests whether a special vitamin B3 tablet, called CICR-NAM, can help people with post-COVID syndrome. The tablet releases nicotinamide in the lower intestine to support energy metabolism. Researchers will give one 500 mg tablet daily for up to 4 months to 100 adults wi…
Sponsor: University Hospital Schleswig-Holstein • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Phone app aims to keep lung cancer patients moving during treatment
Symptom relief Not yet recruitingThis study tests whether a smartphone reminder app can help lung cancer patients stay physically active during radiation therapy. About 32 adults with lung cancer will use the app or standard care, and their daily step counts will be compared. The goal is to see if simple digital…
Sponsor: University Hospital Schleswig-Holstein • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can a simple quiz catch nerve damage early in breast cancer survivors?
Knowledge-focused Not yet recruitingThis study aims to find the best score on a simple, self-administered questionnaire to identify mild nerve damage caused by chemotherapy in breast cancer survivors. About 28 women who have completed taxane-based chemotherapy and radiation will participate. The goal is to improve …
Sponsor: University Hospital Schleswig-Holstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC